Additionally, both gemcitabine-resistant CCA cells showed increased expression of PKC, as well as phosphorylation of FAK and ERK1/2, indicating the involvement of multiple signaling pathways in the chemoresistant behavior of these models. The gene discussed is PRRT2; the disease is cholangiocarcinoma.